je.st
news
Tag: show
China burns half of coal consumption worldwide, figures show
2015-05-31 09:45:00| Climate Ark Climate Change & Global Warming Newsfeed
Guardian: China now burns nearly as much coal as the rest of the world combined. The country's appetite for the carbon-intensive fuel rose by 9% in 2011, to 3.8bn tonnes, meaning it now accounts for 47% of worldwide coal consumption. The growth, revealed by US government figures on Tuesday, was driven by China's booming economy, which has grown at an average rate of around 10% over the past decade. China overtook the US as the world's biggest carbon emitter in 2007, and became the world's biggest consumer...
Tags: show
china
half
worldwide
Texas Instruments employees show off creative chops
2015-05-30 19:13:59| Semiconductors - Topix.net
Would you like to be able to better control the temperature in your home, how well-done your brisket is cooked or how much water your plants receive? Texas Instruments Inc. employees have invented devices to do all of that and more by tinkering with the same technology at home as they do at work. Employees displayed their cool gadgets Friday at the semiconductor company's third annual "DIY with TI" event at its Dallas headquarters.
Tags: show
creative
instruments
texas
Texas Instruments employees show off creative chops
2015-05-30 18:17:48| Electronics - Topix.net
Would you like to be able to better control the temperature in your home, how well-done your brisket is cooked or how much water your plants receive? Texas Instruments Inc. employees have invented devices to do all of that and more by tinkering with the same technology at home as they do at work. Employees displayed their cool gadgets Friday at the semiconductor company's third annual "DIY with TI" event at its Dallas headquarters.
Tags: show
creative
instruments
texas
New Findings Show Durable Anti-Tumor Activity with KEYTRUDA (pembrolizumab), Mercks Anti-PD-1 Therapy, in Patients with Advanced Head and Neck Cancer, Regardless of PD-L1 Expression Status
2015-05-29 20:06:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Results from KEYNOTE-012, the First and Largest Study to Date of an Anti-PD-1 Therapy in Head and Neck Cancer, to be Presented at 2015 ASCO Annual Meeting KEYTRUDA Monotherapy Achieved Overall Response Rate of 25 Percent in Heavily Pre-treated Patients Merck is Advancing a Broad Head and Neck Clinical Program for KEYTRUDA with Five Clinical Trials, Across Multiple Lines of Therapy and in Combination with Other Agents KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced new investigational data evaluating KEYTRUDA (pembrolizumab), the companys anti-PD-1 therapy, as a monotherapy from the KEYNOTE-012 Phase 1b study in 132 pre-treated patients with recurrent or metastatic head and neck cancer, regardless of PD-L1 expression status. Language: English Contact: MerckMedia:Pamela Eisele, 267-664-0282Claire Mulhearn, 908-200-1889orInvestors:Joseph Romanelli, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: show
advanced
status
head
Fabrico Medical to Exhibit Advanced Medical Fabrication Capabilities at the 2015 MD&M East Show
2015-05-29 12:31:08| Industrial Newsroom - All News for Today
Rochester, NY Fabrico Medical, a provider of custom manufacturing services and converter of thin flexible materials for the design-to-manufacture of medical devices and disposables, announces its participation in the 2015 MD and M East Show, Booth #743, June 9-11, 2015, at Jacob K. Javits Convention Center, New...
Tags: show
advanced
east
medical
Sites : [284] [285] [286] [287] [288] [289] [290] [291] [292] [293] [294] [295] [296] [297] [298] [299] [300] [301] [302] [303] next »